We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
APREPITANT RMB, APREPITANT SCP (Southern Cross Pharma Pty Ltd)
Product name
APREPITANT RMB, APREPITANT SCP
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
117 working days (255)
Active ingredients
aprepitant
Registration type
New generic medicine
Indication
APREPITANT RMB, APREPITANT SCP (capsules) in combination with other antiemetic agents, are indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:
- highly emetogenic cancer chemotherapy.
- moderately emetogenic cancer chemotherapy.
APREPITANT RMB, APREPITANT SCP are indicated for the prevention of postoperative nausea and vomiting.